BOSTON, Nov. 22, 2023 /PRNewswire/ -- Sapphiros, a
platform company dedicated to building the next generation of
consumer diagnostic technologies, is proud to announce it has
entered into a distribution agreement with Cencora, Inc. (NYSE:
COR), formerly AmerisourceBergen Corporation.
Under the agreement, Cencora will distribute the Sapphiros
GoToKnow™ COVID-19 Antigen Rapid Tests to pharmacies across
the United States. This strategic
partnership promises to enhance accessibility and convenience for
those seeking reliable COVID-19 testing solutions
nationwide.
In the future, Cencora will also have access to the future
Sapphiros technologies including a fully disposable, low-cost
multiplexed molecular diagnostics platform, additional rapid
lateral flow tests for diseases beyond COVID-19 and the Satio™
novel blood collection patch coming in early 2024.
"This is a significant milestone for our company and further
validates Sapphiros's unique and transformational technologies,"
said Mark Gladwell, CEO of Sapphiros. "We are honored to
partner with Cencora to bring this product as well as future
innovative product offerings directly to patients across
the United States enabling the
consumer to directly access their diagnostic results and manage
their health."
About Sapphiros
Sapphiros, backed by KKR and Neoenta, is a privately held
consumer diagnostics platform company. Sapphiros's portfolio of
capabilities and technologies includes novel sample collection,
next generation diagnostics, computational biology, and printed
electronics, which help consumers access important diagnostic
results globally. Knowing Now Moves Us™
About Cencora
Cencora is a leading global
pharmaceutical solutions organization centered on improving the
lives of people and animals around the world. We partner with
pharmaceutical innovators across the value chain to facilitate and
optimize market access to therapies. Care providers depend on us
for the secure, reliable delivery of pharmaceuticals, healthcare
products, and solutions. Our 46,000+ worldwide team members
contribute to positive health outcomes through the power of our
purpose: We are united in our responsibility to create
healthier futures. Cencora is ranked #11 on the Fortune 500 and #24
on the Global Fortune 500 with more than $250 billion in annual revenue. Learn more
at www.investor.cencora.com
For further information: Sapphiros,
press@sapphiros.com
Photo -
https://mma.prnewswire.com/media/2283196/Sapphiros.jpg
Logo -
https://mma.prnewswire.com/media/1895080/4418411/Sapphiros_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/sapphiros-and-cencora-formerly-amerisourcebergen-corporation-enter-into-distribution-agreement-301995538.html